Literature DB >> 30785624

Efficacy and Posttreatment Effects of Therapist-Delivered Cognitive Behavioral Therapy vs Supportive Psychotherapy for Adults With Body Dysmorphic Disorder: A Randomized Clinical Trial.

Sabine Wilhelm1,2, Katharine A Phillips3,4,5,6, Jennifer L Greenberg1,2, Sheila M O'Keefe1,2, Susanne S Hoeppner1,2, Aparna Keshaviah7, Suraj Sarvode-Mothi1, David A Schoenfeld2,8.   

Abstract

Importance: Cognitive behavioral therapy (CBT), the best-studied treatment for body dysmorphic disorder (BDD), has to date not been compared with therapist-delivered supportive psychotherapy, the most commonly received psychosocial treatment for BDD. Objective: To determine whether CBT for BDD (CBT-BDD) is superior to supportive psychotherapy in reducing BDD symptom severity and associated BDD-related insight, depressive symptoms, functional impairment, and quality of life, and whether these effects are durable. Design, Setting, and Participants: This randomized clinical trial conducted at Massachusetts General Hospital and Rhode Island Hospital recruited adults with BDD between October 24, 2011, and July 7, 2016. Participants (n = 120) were randomized to the CBT-BDD arm (n = 61) or the supportive psychotherapy arm (n = 59). Weekly treatments were administered at either hospital for 24 weeks, followed by 3- and 6-month follow-up assessments. Measures were administered by blinded independent raters. Intention-to-treat statistical analyses were performed from February 9, 2017, to September 22, 2018. Interventions: Cognitive behavioral therapy for BDD, a modular skills-based treatment, addresses the unique symptoms of the disorder. Supportive psychotherapy is a nondirective therapy that emphasizes the therapeutic relationship and self-esteem; supportive psychotherapy was enhanced with BDD-specific psychoeducation and treatment rationale. Main Outcomes and Measures: The primary outcome was BDD symptom severity measured by the change in score on the Yale-Brown Obsessive-Compulsive Scale Modified for BDD from baseline to end of treatment. Secondary outcomes were the associated symptoms and these were assessed using the Brown Assessment of Beliefs Scale, Beck Depression Inventory-Second Edition, Sheehan Disability Scale, and Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form.
Results: Of the 120 participants, 92 (76.7%) were women, with a mean (SD) age of 34.0 (13.1) years. The difference in effectiveness between CBT-BDD and supportive psychotherapy was site specific: at 1 site, no difference was detected (estimated mean [SE] slopes, -18.6 [1.9] vs -16.7 [1.9]; P = .48; d growth-modeling analysis change, -0.25), whereas at the other site, CBT-BDD led to greater reductions in BDD symptom severity, compared with supportive psychotherapy (estimated mean [SE] slopes, -18.6 [2.2] vs -7.6 [2.0]; P < .001; d growth-modeling analysis change, -1.36). No posttreatment symptom changes were observed throughout the 6 -months of follow-up (all slope P ≥ .10). Conclusions and Relevance: Body dysmorphic disorder severity and associated symptoms appeared to improve with both CBT-BDD and supportive psychotherapy, although CBT-BDD was associated with more consistent improvement in symptom severity and quality of life. Trial Registration: ClinicalTrials.gov identifier: NCT01453439.

Entities:  

Mesh:

Year:  2019        PMID: 30785624      PMCID: PMC6450292          DOI: 10.1001/jamapsychiatry.2018.4156

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  34 in total

1.  How important are the common factors in psychotherapy? An update.

Authors:  Bruce E Wampold
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

2.  Body dysmorphic disorder: a cognitive behavioural model and pilot randomised controlled trial.

Authors:  D Veale; K Gournay; W Dryden; A Boocock; F Shah; R Willson; J Walburn
Journal:  Behav Res Ther       Date:  1996-09

3.  Modular cognitive-behavioral therapy for body dysmorphic disorder.

Authors:  Sabine Wilhelm; Katharine A Phillips; Jeanne M Fama; Jennifer L Greenberg; Gail Steketee
Journal:  Behav Ther       Date:  2011-05-01

4.  Metacognitive therapy for body dysmorphic disorder patients in Iran: acceptability and proof of concept.

Authors:  Mehdi Rabiei; Sandra Mulkens; Mehrdad Kalantari; Hossein Molavi; Fatemeh Bahrami
Journal:  J Behav Ther Exp Psychiatry       Date:  2011-10-04

5.  The Brown Assessment of Beliefs Scale: reliability and validity.

Authors:  J L Eisen; K A Phillips; L Baer; D A Beer; K D Atala; S A Rasmussen
Journal:  Am J Psychiatry       Date:  1998-01       Impact factor: 18.112

6.  A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.

Authors:  Katharine A Phillips; Ralph S Albertini; Steven A Rasmussen
Journal:  Arch Gen Psychiatry       Date:  2002-04

7.  Characteristics of memory dysfunction in body dysmorphic disorder.

Authors:  T Deckersbach; C R Savage; K A Phillips; S Wilhelm; U Buhlmann; S L Rauch; L Baer; M A Jenike
Journal:  J Int Neuropsychol Soc       Date:  2000-09       Impact factor: 2.892

8.  Impaired identity recognition of faces with emotional expressions in body dysmorphic disorder.

Authors:  Jamie Donald Feusner; Alexander Bystritsky; Gerhard Hellemann; Susan Bookheimer
Journal:  Psychiatry Res       Date:  2010-05-20       Impact factor: 3.222

9.  Treatment of acute stress disorder: a comparison of cognitive-behavioral therapy and supportive counseling.

Authors:  R A Bryant; A G Harvey; S T Dang; T Sackville; C Basten
Journal:  J Consult Clin Psychol       Date:  1998-10

10.  Assessing therapist reservations about exposure therapy for anxiety disorders: the Therapist Beliefs about Exposure Scale.

Authors:  Brett J Deacon; Nicholas R Farrell; Joshua J Kemp; Laura J Dixon; Jennifer T Sy; Annie R Zhang; Patrick B McGrath
Journal:  J Anxiety Disord       Date:  2013-05-04
View more
  15 in total

1.  Error in Affiliation.

Authors: 
Journal:  JAMA Psychiatry       Date:  2019-04-01       Impact factor: 21.596

2.  A network perspective on body dysmorphic disorder and major depressive disorder.

Authors:  Berta J Summers; George Aalbers; Payton J Jones; Richard J McNally; Katharine A Phillips; Sabine Wilhelm
Journal:  J Affect Disord       Date:  2019-11-05       Impact factor: 4.839

3.  Diagnosis and Treatment of Obsessive-Compulsive and Related Disorders.

Authors: 
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-11-05

4.  Body Dysmorphic Disorder: Clinical Overview and Relationship to Obsessive-Compulsive Disorder.

Authors:  Katharine A Phillips; Megan M Kelly
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-11-05

5.  Early response to cognitive behavioral therapy for body dysmorphic disorder as a predictor of outcomes.

Authors:  Jennifer L Greenberg; Nicholas C Jacobson; Susanne S Hoeppner; Emily E Bernstein; Ivar Snorrason; Anna Schwartzberg; Gail Steketee; Katharine A Phillips; Sabine Wilhelm
Journal:  J Psychiatr Res       Date:  2022-06-08       Impact factor: 5.250

6.  An Evaluation of the Body Dysmorphic Disorder Symptom Scale as a Measure of Treatment Response and Remission in Psychotherapy and Medication Trials.

Authors:  Berta J Summers; Susanne S Hoeppner; Clare C Beatty; Mark A Blais; Jennifer L Greenberg; Katharine A Phillips; Sabine Wilhelm
Journal:  Behav Ther       Date:  2021-12-24

7.  Predictors and moderators of symptom change during cognitive-behavioral therapy or supportive psychotherapy for body dysmorphic disorder.

Authors:  Katharine A Phillips; Jennifer L Greenberg; Susanne S Hoeppner; Hilary Weingarden; Sheila O'Keefe; Aparna Keshaviah; David A Schoenfeld; Sabine Wilhelm
Journal:  J Affect Disord       Date:  2021-03-11       Impact factor: 4.839

8.  Rates of remission, sustained remission, and recurrence in a randomized controlled trial of cognitive behavioral therapy versus supportive psychotherapy for body dysmorphic disorder.

Authors:  Hilary Weingarden; Susanne S Hoeppner; Ivar Snorrason; Jennifer L Greenberg; Katharine A Phillips; Sabine Wilhelm
Journal:  Depress Anxiety       Date:  2021-03-16       Impact factor: 8.128

9.  Greater history of traumatic event exposure and PTSD associated with comorbid body dysmorphic disorder in a large OCD cohort.

Authors:  Jorge Valderrama; Stella Kim Hansen; Carlos Pato; Katharine Phillips; James Knowles; Michele T Pato
Journal:  Psychiatry Res       Date:  2020-05-06       Impact factor: 11.225

10.  Optimizing Smartphone-Delivered Cognitive Behavioral Therapy for Body Dysmorphic Disorder Using Passive Smartphone Data: Initial Insights From an Open Pilot Trial.

Authors:  Hilary Weingarden; Aleksandar Matic; Roger Garriga Calleja; Jennifer L Greenberg; Oliver Harrison; Sabine Wilhelm
Journal:  JMIR Mhealth Uhealth       Date:  2020-06-18       Impact factor: 4.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.